AI-based phone app for long-term epilepsy care in rural China
Tests an AI-assisted phone program for managing epilepsy in rural adults.
Plain-language title generated from the registry record
Registry title: Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas
Key facts
- Where
- Xi'an, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07448233, who can take part
Where in China
- Department of Neurology, Xijing Hospital, Air Force Medical UniversityXi'an, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Xijing Hospital
- Trial code
- NCT07448233
- Record updated
- 4 March 2026
- Original description
This project, titled "Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas ", is led by the First Affiliated Hospital of Air Force Medical University, with Jiang Wen as the principal investigator. It is a prospective, multicenter, cluster-randomized controlled trial involving 756 patients from eight rural counties in China's northwest region. The study aims to evaluate the effectiveness of an AI-assisted remote healthcare system (via a WeChat mini-program) compared to standard care in reducing seizure frequency and improving self-management skills among adult epilepsy patients. Key components include patient and doctor interfaces for features like AI consultations, medication reminders, and online consultations. The trial runs from December 1, 2025, to November 30, 2027, with primary outcomes measured at 12 months and secondary outcomes assessing medication adherence, quality of life, and safety.Read full original descriptionShow less
Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas
This project, titled "Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas ", is led by the First Affiliated Hospital of Air Force Medical University, with Jiang Wen as the principal investigator. It is a prospective, multicenter, cluster-randomized controlled trial involving 756 patients from eight rural counties in China's northwest region. The study aims to evaluate the effectiveness of an AI-assisted remote healthcare system (via a WeChat mini-program) compared to standard care in reducing seizure frequency and improving self-management skills among adult epilepsy patients. Key components include patient and doctor interfaces for features like AI consultations, medication reminders, and online consultations. The trial runs from December 1, 2025, to November 30, 2027, with primary outcomes measured at 12 months and secondary outcomes assessing medication adherence, quality of life, and safety.
Inclusion: Meets ILAE 2017 diagnostic criteria for epilepsy; ≥1 bilateral tonic-clonic seizure in the past 12 months; Aged 18-65 years; Access to a smartphone patient/caregiver; Written informed consent.
Exclusion: Seizures with identifiable triggers e.g., alcohol withdrawal; Severe comorbidities e.g., organ dysfunction, malignancy, psychiatric disorders; Allergy to phenobarbital/sodium valproate; Pregnancy, lactation, or planned pregnancy.